We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Irritable bowel syndrome (IBS)
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Irritable bowel syndrome (IBS) is a common condition which causes symptoms of abdominal pain, bloating and altered bowel habits. Conventional treatment is frequently unsatisfactory. The study does not involve a medicine. The researchers wish to explore whether giving a food supplement called JUVIA will improve symptoms of IBS. JUVIA is an enzyme-rich malt extract (ERME) that contains a high concentration of enzymes that digest carbohydrates that aim to improve symptoms of IBS. ERME is a by-product of the malting process, in which cereal grains (like barley) are dried. It is sweet and easy to drink and has been used for many years in baking and cookery.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Pregnant, planning to become pregnant or lactating2. Diabetic (or other co-morbidity that the CI considers inappropriate)3. On a restrictive diet or unwilling or unable to change diet4. Current medication (e.g. opiates) that may influence bowel symptoms (at the discretion of the CI)5. Antibiotics in the previous 6 weeks6. Other gastrointestinal disease (e.g. coeliac, Crohn’s disease or Ulcerative colitis )7. Significant gastrointestinal surgery (this will be a clinical decision and any patient who has had a surgical procedure that would change the mechanics of gut function would be excluded)8. Involved in other gastroenterology research project or other interventional study that would affect results
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Prof
Stephen
Bain
+44 (0)1792 530819
s.c.bain@swansea.ac.uk
The study is sponsored by Ateria Health Ltd and funded by Ateria Health Ltd.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 55644
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
